Savant Capital, LLC Novartis Ag Transaction History

Savant Capital, LLC

$17.8 Billion
Q3 2025

A detailed history of Savant Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Savant Capital, LLC holds 19,041 shares of NVS stock, worth $2.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,041

Previous 17,076 11.51%

Holding current value

$2.5 Million

Previous $2.07 Million 18.15%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$113.5 - $129.73 $223,027 - $254,919	1,965 Added 11.51%	19,041 $2.44 Million
Q2 2025 Aug 06, 2025	BUY	$101.96 - $121.01 $460,247 - $546,239	4,514 Added 35.93%	17,076 $2.07 Million
Q1 2025 May 08, 2025	BUY	$97.14 - $115.57 $114,625 - $136,372	1,180 Added 10.37%	12,562 $1.4 Million
Q4 2024 Jan 28, 2025	BUY	$96.78 - $117.18 $1,064 - $1,288	11 Added 0.1%	11,382 $1.11 Million
Q3 2024 Nov 04, 2024	BUY	$106.13 - $120.89 $627,016 - $714,218	5,908 Added 108.15%	11,371 $1.31 Million

Q2 2024 Aug 05, 2024	BUY	$92.57 - $107.37 $5,183 - $6,012	56 Added 1.04%	5,463 $581,000
Q1 2024 May 03, 2024	SELL	$95.27 - $108.47 $199,685 - $227,353	-2,096 Reduced 27.94%	5,407 $523,000
Q4 2023 Feb 05, 2024	BUY	$92.27 - $101.54 $344,905 - $379,556	3,738 Added 99.28%	7,503 $757,000
Q3 2023 Nov 06, 2023	SELL	$94.73 - $105.13 $31,450 - $34,903	-332 Reduced 8.1%	3,765 $383,000
Q2 2023 Aug 04, 2023	BUY	$92.52 - $104.91 $51,718 - $58,644	559 Added 15.8%	4,097 $413,000
Q1 2023 May 02, 2023	SELL	$80.03 - $92.81 $1,680 - $1,949	-21 Reduced 0.59%	3,538 $325,000
Q4 2022 Feb 06, 2023	BUY	$75.55 - $92.52 $268,882 - $329,278	3,559 New	3,559 $322,000
Q2 2022 Jul 22, 2022	BUY	$80.52 - $93.75 $15,781 - $18,375	196 Added 6.91%	3,034 $256,000
Q1 2022 May 05, 2022	SELL	$80.11 - $90.62 $1,922 - $2,174	-24 Reduced 0.84%	2,838 $249,000
Q4 2021 Feb 08, 2022	BUY	$79.7 - $88.13 $25,982 - $28,730	326 Added 12.85%	2,862 $250,000
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $17,746 - $20,645	-217 Reduced 7.88%	2,536 $207,000
Q2 2021 Aug 04, 2021	SELL	$85.24 - $94.15 $18,497 - $20,430	-217 Reduced 7.31%	2,753 $251,000
Q1 2021 May 04, 2021	SELL	$83.5 - $98.47 $2,505 - $2,954	-30 Reduced 1.0%	2,970 $254,000
Q4 2020 Feb 03, 2021	BUY	$78.07 - $94.43 $546 - $661	7 Added 0.23%	3,000 $283,000
Q3 2020 Nov 04, 2020	SELL	$82.14 - $91.0 $14,703 - $16,289	-179 Reduced 5.64%	2,993 $260,000
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $32,695 - $36,804	404 Added 14.6%	3,172 $277,000
Q1 2020 Apr 30, 2020	BUY	$70.67 - $99.01 $195,614 - $274,059	2,768 New	2,768 $228,000

Others Institutions Holding NVS

# of Institutions

1,610

Shares Held

137M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Account

Savant Capital, LLC Novartis Ag Transaction History